Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...

Now, when we think historically about the outcomes for cisplatin-ineligible metastatic urothelial cancer, the median survival ...

Enter the game-changer—two Pt-MSA-2 conjugates (I and II). These ingenious compounds bring together the DNA-damaging power of cisplatin and the immune-activating strength of STING agonist MSA-2.

Another drug that’s in short supply is cisplatin, which has been the backbone for lung cancer regimens for many years. The National Comprehensive Cancer Network, an alliance of 33 U.S. cancer ...

Cisplatin is one of the most widely used agents in the treatment of solid tumors, but its clinical utility is limited by toxicity. The development of less toxic, liposomal formulations of ...

The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant ...

The reference arm of paciltaxel and cisplatin for the Monk et al. 3 trial was selected on the basis of results from a GOG randomized phase III study, which demonstrated an improvement in objective ...

Capsaicin, the compound in chili peppers which gives them their spicy taste, may become a source of new, natural drugs for ...

Ferroptosis offers new strategies to combat treatment resistance in digestive tract cancers, enhancing the efficacy of ...

Bevacizumab in combination with atezolizumab and chemotherapy led to improvements in progression-free survival and duration ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young ...